Electric pulses and chemo aim to stop pancreatic cancer return
NCT ID NCT04281290
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests whether applying electrochemotherapy (electric pulses plus the drug bleomycin) to the area where a pancreatic tumor was removed can lower the chance of cancer coming back. Ten patients with resectable pancreatic cancer will receive the treatment during surgery. The main goal is to check safety and see if it reduces local recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bleomycin
What this could lead to
If it works, this could point toward a way to reduce local recurrence after pancreatic cancer surgery.
What could go wrong
This is a very early, small trial (10 patients) testing safety and feasibility. It may not show a clear benefit, and there are risks from surgery and the electrochemotherapy procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Centre Ljubljana, Ljubljana, Slovenia
Ljubljana, 1000, Slovenia